Search

everythinglearnresearchcommunity

for

Search:↓

Modifying steroidal inhibitors shows promise for developing new cancer treatments.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

Abietic acid from pine resin can effectively inhibit testosterone 5α-reductase.

SIG-1451 could be a promising new treatment for atopic dermatitis.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

Etanercept improved symptoms of a specific type of psoriatic arthritis in a patient who didn't respond to other treatments.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

Using existing drugs for new purposes can effectively treat infections resistant to multiple antibiotics.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

Anticancer drugs are increasingly found in surface waters, and their long-term environmental effects are not well understood, requiring better testing methods.

Celiac disease requires more than just a gluten-free diet for effective management.

Topical finasteride may help treat facial hirsutism in women.

5α-reductase inhibitors, like finasteride and dutasteride, effectively treat BPH, male baldness, and hirsutism, with potential for acne and prostate cancer prevention.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

A new compound effectively inhibits human 5α-reductase 1.

Dihydrotestosterone (DHT) stops hair growth in mice by lowering a growth factor important for hair.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

The developed model can predict effective 5-alpha-reductase enzyme inhibitors.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.